Supriya Lifescience Ltd (SUPRIYA)
₹384.45▲0.48%
Analyst Rating
based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 1 analysts offering long term price targets for Supriya Lifescience Ltd. An average target of ₹401
Source: S&P Global Market Intelligence
Supriya Lifescience Ltd Share analysis
Source: S&P Global Market Intelligence
Performance
Day's Low
Day's High
₹382.1₹389.9552 Week's Low
52 Week's High
₹234.9₹424.7
| Returns % | |
| 1 Month Return | -2.44 % |
| 3 Month Return | -4.9 % |
| 1 Year Return | + 58.85 % |
| Market Stats | |
| Previous Close | ₹382.60 |
| Open | ₹382.10 |
| Volume | 1.26L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹3,079.27Cr |
Key Statistics
| P/E Ratio | 0 |
| PEG Ratio | 0 |
| Market Cap | ₹3,079.27 Cr |
| P/B Ratio | 2.19 |
| EPS | 0 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹3,079.27 Cr | -0.42% | 0.52 | NA | NA |
 | NA | ₹17.18 Cr | -6.84% | 0.50 | -₹3 Cr | ₹45 Cr |
| NA | ₹164.28 Cr | 90.19% | 0.58 | NA | NA |
 | NA | ₹1,131.02 Cr | 120.9% | 0.54 | ₹27 Cr | ₹550 Cr |
| NA | ₹14.76 Cr | 80.9% | 0.69 | NA | NA |
Company Information
Share Price: ₹384.45 per share as on 24 Jul, 2024 04:01 PM
Market Capitalisation: ₹3,079.27Cr as of today
Listing date: 28 Dec, 2021
Chairperson Name: Satish Waman Wagh
| Organisation | Supriya Lifescience Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Supriya Lifescience Ltd
Supriya Lifescience Beats Revenue and EBITDA Estimates - 13 Jun, 2024
Supriya Lifescience's revenue beat estimates by 5.8% due to growth in Vitamin and Anti-Histamine segment, while EBITDA beat estimates by 22.4% due to lower expenses. The stock is trading at 19.3x/15.6x based on FY25E/FY26E EPS respectively, with a target price of INR 401/share and a BUY rating. Regulated market share expected to increase, watch for Ambernath facility commencement, new product launches, and commercialized contracts.
Supriya Lifescience Ltd's Cash Conversion Less Than Ideal - 05 Jun, 2024
Supriya Lifescience Limited's accrual ratio for the last twelve months signifies cash conversion is less than ideal, which is a negative when it comes to our view of its earnings. Its earnings per share increased by 33% in the last year. However, the company had negative free cash flow of ₹323m despite its profit of ₹1.19b, which might indicate high risk.
Supriya Lifescience Reports Strong FY 2024 Earnings - 30 May, 2024
Supriya Lifescience reported a strong FY 2024 with an EPS of ₹14.80, up from ₹11.17 in FY 2023. The company's revenue and net income increased by 26% and 33%, respectively, compared to the previous year. Looking ahead, revenue is forecasted to grow at 18% p.a., higher than the industry average of 10%. However, the stock price has dropped by 6.5% from a week ago.
Insights on Supriya Lifescience Ltd
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 21.04% to 21.27% in Jun 2024 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 0.05% to 0.13% in Jun 2024 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 68.30% of holdings in Jun 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 28.3%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 5.36% to 4.95% in Jun 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, SUPRIYA stock has moved down by -4.3%
Company Financials
| 2023 | Y/Y Change | |
|---|---|---|
Total Assets | ₹823.46Cr | ↑11.71% |
Total Liabilities | ₹124.00Cr | ↑2.10% |
| 2023 | Y/Y Change | |
|---|---|---|
Operating Cash Flow | ₹66.19Cr | ↑35.64% |
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 68.3% | 0.00 | |
| Foreign Institutions | 4.95% | ||
| Mutual Funds | 0.13% | 170.93 | |
| Retail Investors | 21.27% | 1.10 | |
| Others | 5.35% | 1.86 |
Key Indicators
Earnings and Dividends
Supriya Lifescience Ltd Earnings Results
Supriya Lifescience Ltd’s net profit fell -3.4% since last year same period to ₹36.93Cr in the Q4 2023-2024. On a quarterly growth basis, Supriya Lifescience Ltd has generated 23.97% jump in its net profits since last 3-months.
Read More about Earnings ResultsSupriya Lifescience Ltd Dividends May,2023
In the quarter ending March 2023, Supriya Lifescience Ltd has declared dividend of ₹0.60 - translating a dividend yield of 0.16%.
Read More about Dividends
Technicals Summary
Bearish
Neutral
Bullish
Supriya Lifescience Ltd is currently in a Bearish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Supriya Lifescience Ltd shares.
Supriya Lifescience Ltd (SUPRIYA) share price today is ₹384.45
Supriya Lifescience Ltd is listed on NSE
Supriya Lifescience Ltd is listed on BSE
- Today’s highest price of Supriya Lifescience Ltd is ₹389.95.
- Today’s lowest price of Supriya Lifescience Ltd is ₹382.1.
Today’s traded volume of Supriya Lifescience Ltd(SUPRIYA) is 1.26L.
Today’s market capitalisation of Supriya Lifescience Ltd(SUPRIYA) is ₹3079.27Cr.
| Supriya Lifescience Ltd(SUPRIYA | Price |
|---|---|
52 Week High | ₹424.7 |
52 Week Low | ₹234.9 |
Supriya Lifescience Ltd(SUPRIYA) share price is ₹384.45. It is down -9.48% from its 52 Week High price of ₹424.7
Supriya Lifescience Ltd(SUPRIYA) share price is ₹384.45. It is up 63.67% from its 52 Week Low price of ₹234.9
| Supriya Lifescience Ltd(SUPRIYA | Returns |
|---|---|
1 Day Returns | 1.85% |
1 Month Returns | -2.44% |
3 Month Returns | -4.9% |
1 Year Returns | 58.85% |